Balaxi Pharmaceuticals Limited has submitted its Registrar and Share Transfer Agent (RTA) report to the National Stock Exchange of India Limited. This report pertains to the re-lodgement of transfer requests for physical shares, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated 30th January, 2026. The report, received from M/s. Aarthi Consultants Private Limited, covers the period ended June 2026. According to the RTA's confirmation, there were no requests received, processed, approved, or rejected during the month of June 2026. Consequently, the average time taken for processing requests was also NIL. The company has also confirmed that this information will be made available on their website, www.balaxipharma.in. This disclosure is in compliance with SEBI regulations regarding the handling of physical share transfers.
